PubRank

I Heron

Author PubWeight™ 111.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991 3.69
2 A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A 1971 2.55
3 T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991 2.43
4 Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun 1993 2.27
5 Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet 1984 2.16
6 Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol 1992 2.05
7 Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A 1978 1.98
8 Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun 1987 1.96
9 Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun 1988 1.70
10 Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun 1990 1.66
11 Regulatory effect of interferon on T cells in vitro. J Immunol 1976 1.62
12 Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet 1985 1.54
13 In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology 1977 1.45
14 Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol 1988 1.44
15 Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 1999 1.33
16 ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 1986 1.32
17 Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods 1993 1.32
18 Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine 1987 1.25
19 Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand 1987 1.23
20 Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun 1992 1.16
21 Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology 1983 1.14
22 The migration of lymphocytes in the fetal lamb. Eur J Immunol 1979 1.12
23 Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis 1988 1.11
24 Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun 1977 1.11
25 Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene 2006 1.09
26 Bordetella pertussis and chronic cough in adults. Clin Infect Dis 1999 1.06
27 The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C 1987 1.00
28 Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis 1997 0.99
29 Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol 1982 0.96
30 Lymphocyte recirculation in the sheep fetus. Ciba Found Symp 1980 0.96
31 Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol 1990 0.96
32 T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology 1982 0.96
33 The actions of interferon are potentiated at elevated temperature. Nature 1978 0.96
34 Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine 1997 0.95
35 Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst 1988 0.95
36 Bordetella pertussis diagnosed by polymerase chain reaction. APMIS 1994 0.94
37 Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C 1987 0.93
38 Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol 1994 0.93
39 Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol 1979 0.92
40 The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C 1986 0.92
41 Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine 1996 0.92
42 Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A 1993 0.91
43 Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS 1992 0.91
44 The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol 1980 0.90
45 Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol 1987 0.90
46 Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine 1993 0.90
47 Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS 1997 0.89
48 Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res 1981 0.89
49 The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol 1979 0.89
50 Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods 1996 0.89
51 An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods 1976 0.89
52 The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol 1991 0.88
53 Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine 1998 0.88
54 Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun 1977 0.88
55 Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol 1995 0.87
56 Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS 1996 0.86
57 Is the acute encephalopathy test in mice suited for control of pertussis vaccines? Dev Biol Stand 1985 0.86
58 Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol 1978 0.86
59 Immunity to tetanus and diphtheria in rural Africa. Am J Trop Med Hyg 1997 0.86
60 Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Acta Pathol Microbiol Immunol Scand C 1986 0.85
61 Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro. Clin Exp Immunol 1981 0.85
62 Characterisation of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous haemagglutinin production, cellular fatty acid composition and antibiotic sensitivity. FEMS Microbiol Lett 1995 0.84
63 Stimulation of human lymphocytes by cytomegalovirions and dense bodies. Med Microbiol Immunol 1978 0.83
64 Occurrence of cytotoxic antibodies during pregnancy. Vox Sang 1971 0.82
65 Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine. Scand J Infect Dis 1999 0.82
66 Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics. Vaccine 1995 0.82
67 A paraffin embedding method in kidney immunofluorescent studies. Acta Pathol Microbiol Scand B Microbiol Immunol 1970 0.82
68 Proliferative response to seven affinity purified mycobacterial antigens in eight strains of inbred mice. Int J Lepr Other Mycobact Dis 1991 0.82
69 13 native human interferon-alpha species assessed for immunoregulatory properties. J Interferon Res 1983 0.82
70 Identification of human T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun 1992 0.82
71 Human leucocyte interferon: analysis of effect on MLC and effector cell generation. Scand J Immunol 1979 0.81
72 Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. Vaccine 1998 0.81
73 Postimmunization activity of oligoadenylate synthetase in peripheral blood lymphocytes from healthy individuals. J Clin Lab Immunol 1989 0.81
74 Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia. Leukemia 1995 0.81
75 Immune response to other agents of calves persistently infected with bovine virus diarrhoea virus (BVDV). Acta Vet Scand 1993 0.80
76 Modification of lymphocyte response to phytomitogens by polycations and polyanions. Experientia 1978 0.80
77 Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virus. Infect Immun 1978 0.80
78 Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II. Vaccine 1995 0.80
79 Cell mediated lympholysis in man. A case of "non relevant" killing of third party persons. Tissue Antigens 1974 0.80
80 The complete purification of human leucocyte interferon. Scand J Immunol 1980 0.80
81 Purification of human interferon by antibody affinity chromatography, using highly absorbed anti-interferon. Scand J Immunol 1978 0.80
82 Immunity against tetanus and response to revaccination in surgical patients more than 50 years of age. Surg Gynecol Obstet 1987 0.79
83 Induction of polyclonal antibodies to the S1 subunit of pertussis toxin by synthetic peptides coupled to PPD: effect of conjugation method, adjuvant, priming and animal species. APMIS 1992 0.79
84 Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun 1993 0.79
85 Epidemiology of tetanus in Denmark 1920-1982. Scand J Infect Dis 1987 0.79
86 Determination of tetanus and diphtheria antitoxin content in dried samples of capillary blood: a convenient method applied to infants. Scand J Infect Dis 1987 0.79
87 Kidney transplantation in the rabbit. A new method. Acta Pathol Microbiol Scand A 1970 0.79
88 Revaccination of adults against diphtheria. I: Responses and reactions to different doses of diphtheria toxoid in 30-70-year-old persons with low serum antitoxin levels. Acta Pathol Microbiol Immunol Scand C 1986 0.79
89 In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise. Med Sci Sports Exerc 1997 0.79
90 Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro. Eur J Cancer 1980 0.79
91 Culture phenotypes and molecular characterization of Mycobacterium avium subsp. paratuberculosis isolates from small ruminants. Res Vet Sci 2013 0.79
92 Cytotoxic antibodies and accellerated rejection of the transplanted rabbit heart. The effect of presensitization. Acta Pathol Microbiol Scand A 1971 0.78
93 Studies on postpartum rats accepting heart allografts: evidence for immunological enhancement. Transplantation 1972 0.78
94 The effect of conjugation on immunogenicity and potency of protein carriers of polyribosylribitol phosphate (PRP) conjugated vaccines in the mouse model. APMIS 1998 0.78
95 Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin. APMIS 1994 0.78
96 Selective effects of alpha interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol 1983 0.78
97 Interferon-induced augmentation of cytotoxic killer cell generation in mixed lymphocyte cultures: analysis of the effector cell product. Scand J Immunol 1981 0.78
98 Human lymphocyte and mouse erythrocyte rosettes. Optimization of the assay. Scand J Haematol 1981 0.77
99 Evaluation of local toxicity after repeated intranasal vaccination of guinea-pigs. Toxicology 1996 0.77
100 Hemodynamics of graft-versus-host reactions in the rat lymph node. Transplantation 1978 0.77
101 SDS-polyacrylamide gel electrophoresis of purified human leucocyte interferon and the antiviral and anticellular activities of the different interferon species. J Gen Virol 1980 0.77
102 Identification of B-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun 1993 0.77
103 The generation of guinea pig T-cell lines reactive to antigens from Mycobacterium tuberculosis. Selected lines induce erythematous skin reactions. Scand J Immunol 1989 0.77
104 WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines. Biologicals 1998 0.77
105 Improvement of a Vero cell assay to determine diphtheria antitoxin content in sera. Biologicals 1991 0.77
106 Quantitation of pertussis toxin in an enzyme linked immunosorbent assay with improved specificity. Biologicals 1990 0.76
107 Lipopolysaccharides in a traditional pertussis vaccine. J Biol Stand 1988 0.76
108 Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I. Vaccine 1995 0.76
109 Cellular immune responses of the rat to experimental infection with Dermatophilus congolensis. Vet Microbiol 1990 0.75
110 Prolonged survival of heart allografts transplanted in rats and rabbits following pregnancy. Transplantation 1972 0.75
111 Local lymph node response in rats to allogeneic stimulus: analysis of the in vitro responding cells. Acta Pathol Microbiol Scand C 1977 0.75
112 [The immune regulatory function of interferon]. Ugeskr Laeger 1978 0.75
113 Quantitative estimation of diphtheria and tetanus toxoids. 3. Comparative assays in mice and in guinea-pigs of two tetanus toxoid preparations. Biologicals 1990 0.75
114 Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay. Dev Biol Stand 1996 0.75
115 A possible association between CFA (I) fimbriae and K99 fimbriae on Escherichia coli and bacterial adherence to human lymphocytes. Acta Pathol Microbiol Scand B 1980 0.75
116 [Immunity to diphtheria in people aged 25-30]. Ugeskr Laeger 1985 0.75
117 [Revaccination against tetanus 25-30 years after primary vaccination]. Ugeskr Laeger 1985 0.75
118 Micro complement fixation test for typing of platelets. A new method. Vox Sang 1971 0.75
119 Analysis of the lymphocyte distribution during Isopaque-Ficoll isolation of mononuclear cells from human peripheral blood. J Immunol Methods 1980 0.75
120 Quantitative estimation of diphtheria and tetanus toxoids. 5. Comparative assays in mice and in guinea-pigs of two diphtheria toxoid preparations. Biologicals 1991 0.75
121 Antibody affinity chromatography of human leukocyte interferon. Methods Enzymol 1981 0.75
122 Suppression of cardiac allograft rejection in adult rats by pretreatment with bone marrow cells. Immunological enhancement. Acta Pathol Microbiol Scand B Microbiol Immunol 1972 0.75
123 Effect of mycoplasmas on phagocytosis and immunocompetence in rats. Acta Pathol Microbiol Scand C 1979 0.75
124 The effect of interferon on ADCC (I). Acta Pathol Microbiol Immunol Scand C 1983 0.75
125 Effects of interferon on human lymphoid cells and their function. Ann N Y Acad Sci 1980 0.75
126 Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine. Vaccine 1993 0.75
127 The appearance of specific helper cells in lymph of immunized sheep. Int Arch Allergy Appl Immunol 1982 0.75
128 The effect of pregnancy on rejection of allotransplanted hearts in the rabbit and rat. Acta Pathol Microbiol Scand B Microbiol Immunol 1971 0.75
129 The iso--and allotransplanted rat heart. Histological, electrocardiographic and serological observations. Acta Pathol Microbiol Scand A 1972 0.75
130 Procedures for the mixed lymphocyte reaction and cell-mediated lympholysis. Methods Enzymol 1981 0.75
131 Cytotoxic antibodies in serum of pregnant women at delivery. Acta Pathol Microbiol Scand B Microbiol Immunol 1971 0.75
132 [Immunity to tetanus among the 25 to 30-year-old population]. Ugeskr Laeger 1984 0.75
133 Ranitidine improves postoperative suppression of antibody response to preoperative vaccination. Surgery 1992 0.75
134 Spontaneous rosette-forming lymphocytes in sheep lymph. A marker for antigen-binding cells. Cell Immunol 1978 0.75
135 Inhibition of the mixed leucocyte reaction by histocompatibility antibodies requires the Fc part. Transplantation 1977 0.75
136 Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response. J Trauma 1987 0.75
137 [Immunopathological views on nephritis]. Nord Med 1970 0.75
138 Two small lymphocyte subpopulations in human peripheral blood. II. Functional characterization in vitro. Int Arch Allergy Appl Immunol 1978 0.75
139 Intranasal vaccination: pharmaceutical evaluation of the vaccine delivery system and immunokinetic characteristics of the immune responses. Pharm Dev Technol 1998 0.75
140 Regional lymph node response in rats to injection of semi-allogeneic lymphocytes. Time, weight, dose, and histocompatibility relations. Acta Pathol Microbiol Scand B Microbiol Immunol 1973 0.75
141 Antibody responses against Mycobacterium tuberculosis and production of monoclonal antibodies in mice. Acta Leprol 1989 0.75
142 Induction of haemolytic plaque-forming cells with sheep lymphoid cells in vitro. J Immunol Methods 1978 0.75
143 Diet and immune response in nu/nu Balb/c mice. Exp Cell Biol 1984 0.75
144 Monoclonal antibodies against pertussis toxin. Biochemical characterization and biological activity. Ann Sclavo Collana Monogr 1986 0.75
145 Epstein-Barr virus and chromosomal defects: a family study. Lancet 1981 0.75
146 Purification and characterization of the HuIFN-alpha species. Tex Rep Biol Med 1983 0.75
147 [Transfer factor in mycosis fungoides]. Ugeskr Laeger 1977 0.75
148 Acute unmodified kidney allograft rejection in the rabbit. Histological and immunofluorescent observations. Acta Pathol Microbiol Scand A 1971 0.75
149 Effects of polycationic compounds on mitogen stimulation. Acta Pathol Microbiol Scand C 1980 0.75
150 [Immunofluorescence microscopy used in nephropathology]. Nord Med 1970 0.75
151 [Immunity to tetanus in persons 30 to 70 years old]. Ugeskr Laeger 1986 0.75
152 [Immunity to tetanus and diphtheria in children aged 8 to 11]. Ugeskr Laeger 1987 0.75
153 Passenger cells in rat heart allografts. No effect of removal. Transplantation 1975 0.75
154 [Immunogenicity and safety of Di-Te-Ki-Pol vaccine "SSI" in Danish infants]. Ugeskr Laeger 2000 0.75
155 Letter: The retention of graft-versus-host-reactive host lymphocytes in a vascularized spleen graft. Transplantation 1974 0.75
156 Synergistic teratogenic effect produced in mice by whole cell pertussis vaccine. Vaccine 1987 0.75
157 Age-dependent allospecific change in susceptibility to local lymph node GVHR in rats. Scand J Immunol 1981 0.75
158 Purification of human interferons by antibody affinity chromatography. Tex Rep Biol Med 1977 0.75
159 Antibody-mediated immunosuppression. Comparison of syngeneic and allogeneic antibodies. Vox Sang 1979 0.75
160 [Tetanus 1978-1982]. Ugeskr Laeger 1986 0.75
161 The relationship between human T-lymphocyte subsets defined by monoclonal antibodies and by avidity differences to sheep erythrocytes. Acta Pathol Microbiol Immunol Scand C 1982 0.75
162 The role of HLA-DR antigens in PPD-stimulated lymphocyte-monocyte interactions. Scand J Immunol 1982 0.75
163 Detoxification of diphtheria and tetanus toxin with formaldehyde. Detection of protein conjugates. Biologicals 1992 0.75
164 Quantitative estimation of diphtheria and tetanus toxoids. 6. Use of different antibody titration methods for evaluation of immunogenicity in animals during potency assay of diphtheria toxoid. Biologicals 1992 0.75
165 [Immunity to diphtheria in the 30-70 year-age group]. Ugeskr Laeger 1986 0.75
166 The effect of cyclodextrin on lipopolysaccharide production in cultures of Bordetella pertussis. J Biol Stand 1989 0.75
167 [Immunoregulating proteins]. Ugeskr Laeger 1978 0.75
168 [B and T lymphocytes in the blood]. Ugeskr Laeger 1979 0.75
169 Immunomodulation by Corynebacterium parvum in normal humans. J Immunol 1980 0.75
170 Mixed lymphocyte culture responses in infertile couples. Int J Fertil 1977 0.75
171 Measurements of changes in histocompatibility antigens induced by interferons. Methods Enzymol 1986 0.75
172 [Natural killer cells in man]. Ugeskr Laeger 1981 0.75
173 Cell-mediated immune response in rats during acute allograft rejection and in rats developing allograft acceptance due to passive enhancement. Tissue Antigens 1973 0.75
174 Role of blocking serum factors in organ grafted rats. Acta Pathol Microbiol Scand B Microbiol Immunol 1973 0.75
175 [Indications for preventive human tetanus immune globulins]. Ugeskr Laeger 1987 0.75
176 The effect of prophylaxis with chloroquine and proguanil on delayed-type hypersensitivity and antibody production following vaccination with diphtheria, tetanus, polio, and pneumococcal vaccines. Am J Trop Med Hyg 1991 0.75
177 Is transplantation tolerance in the rat serum-mediated? Transplantation 1973 0.75
178 The transplanted rabbit heart. Histological, immunofluorescent and electrocardiographic changes. Acta Pathol Microbiol Scand A 1971 0.75
179 Changing patterns of lymphocyte circulation during development. Blood Cells 1980 0.75
180 Effector cell potential of two human T-cell subpopulations with different affinities to sheep erythrocytes. Scand J Immunol 1980 0.75
181 Effects of basic proteins on spontaneous rosette formation between human lymphocytes and xenogeneic erythrocytes. Int Arch Allergy Appl Immunol 1981 0.75
182 Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models. Biologicals 1999 0.75
183 Cardiac allograft rejection during and following pregnancy in the inbred rat. Transplantation 1971 0.75
184 Functional characterization in vitro of two human T-cell subpopulations with different affinities to sheep erythrocytes. Scand J Immunol 1979 0.75
185 The human mixed lymphocyte reaction responder and stimulator capacities of highly purified T- and non-T cells and the role of monocytes. Acta Pathol Microbiol Scand C 1979 0.75